Safeguarding patients from adulterated complementary health products: Responsibilities of TCM practitioners
4 November 2026
Audiences
Healthcare professional
Product-type
Chinese Proprietary Medicines
Others
Traditional medicines
Dear Traditional Chinese Medicine Practitioner
The Health Sciences Authority (HSA) would like to inform Traditional Chinese Medicine (TCM) Practitioners of their responsibilities to safeguard patients from adulterated complementary health products. TCM practitioners are advised to comply with HSA’s regulatory requirements when procuring or importing these products, exercise due diligence in their procurement practices, and remain vigilant of the possibility of patient exposure to adulterated products. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg (opens in new tab) and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
